跳至主要内容
临床试验/NCT00700141
NCT00700141已完成不适用

Non-Interventional Study on the Use of TachoSil® During Thyroid Surgery

Nycomed1 个研究点 分布在 1 个国家目标入组 482 人开始时间: 2008年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Nycomed
入组人数
482
试验地点
1
主要终点
Assessment of TachoSil® by the Surgeon With Respect to Handling, Utility and Satisfaction in the Operation, Documented Using 10 Point Numerical Rating Scales

研究概览

简要总结

Considering the total number of thyroid procedures in Germany (100000 - 120000 cases per year), TachoSil® is a valuable tool to support surgical haemostasis, avoiding lymph leaks and support speech-nerve saving approaches. The aim of this study was to evaluate a patient and procedure profile where TachoSil® is most beneficial.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing total or subtotal thyroidectomy

排除标准

  • Contraindications, such as hypersensitivity to the active pharmaceutical ingredient or to another ingredient

结局指标

主要结局

Assessment of TachoSil® by the Surgeon With Respect to Handling, Utility and Satisfaction in the Operation, Documented Using 10 Point Numerical Rating Scales

时间窗: after surgery

Handling (1= very good to 10= very poor) Satisfaction (1= very satisfied to 10= totally unsatisfied) Utility (1= very useful to 10= completely useless)

次要结局

  • Pharmacoeconomic Benefits as Assessed by the Surgeon(peri- and post-surgery until hospital discharge)

研究者

发起方
Nycomed
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验